The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Tuomey, David Spencer
    Director born in May 1970
    Individual (35 offsprings)
    Officer
    2013-01-24 ~ dissolved
    OF - Director → CIF 0
Ceased 3
  • 1
    Bradshaw, Jamie Nicholas
    Director born in May 1976
    Individual (8 offsprings)
    Officer
    2013-02-19 ~ 2019-07-26
    OF - Director → CIF 0
  • 2
    Kelly, Andrew George
    Consultant born in August 1959
    Individual (20 offsprings)
    Officer
    2013-01-24 ~ 2013-01-25
    OF - Director → CIF 0
  • 3
    Reardon, Dayton T
    Professor born in July 1955
    Individual
    Officer
    2013-01-24 ~ 2017-07-01
    OF - Director → CIF 0
parent relation
Company in focus

QOL THERAPEUTICS UK LIMITED

Previous name
QOL THERAPEUTICS EU LTD - 2014-01-22
Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Cash at bank and in hand
6,899 USD2016-01-31
11,190 USD2015-01-31
Current liabilities
-16,368 USD2016-01-31
-17,744 USD2015-01-31
Net assets/liabilities including pension asset/liability
-9,469 USD2016-01-31
-6,554 USD2015-01-31
Called-up share capital
3,213 USD2016-01-31
3,213 USD2015-01-31
Retained earnings
-12,682 USD2016-01-31
-9,767 USD2015-01-31
Shareholder's fund
-9,469 USD2016-01-31
-6,554 USD2015-01-31
Par Value of Share
Class 1 ordinary share
1 USD2015-02-01 ~ 2016-01-31
Number of shares allotted
Class 1 ordinary share
2,000 shares2016-01-31
2,000 shares2015-01-31

  • QOL THERAPEUTICS UK LIMITED
    Info
    QOL THERAPEUTICS EU LTD - 2014-01-22
    Registered number 08373884
    5 The Green, Richmond, Surrey TW9 1PL
    Private Limited Company incorporated on 2013-01-24 and dissolved on 2020-09-29 (7 years 8 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.